Ototoxicity

22 registered clinical trials studyying Ototoxicity — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial NCT07364747	Siriraj Hospital	Phase 2
Completed	Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy NCT06553157	Minia University	Phase 1 / Phase 2
Recruiting	Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma NCT05641441	University Hospital, Geneva	—
Completed	Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing NCT07254442	Zonguldak Bulent Ecevit University	—
Terminated	Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity NCT04226456	Centre Hospitalier Universitaire Saint Pierre	Phase 4
Completed	Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer NCT04262336	Decibel Therapeutics	Phase 1
Recruiting	Treatment of Radiation and Cisplatin Induced Toxicities with Tempol NCT03480971	Matrix Biomed, Inc.	Phase 2
Unknown	SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss NCT01451853	Sound Pharmaceuticals, Incorporated	Phase 2
Completed	SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity NCT02819856	Sound Pharmaceuticals, Incorporated	Phase 2
Withdrawn	Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin NCT02382068	Aaron Moberly	N/A
Completed	Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy NCT01848457	Children's Hospital of Philadelphia	Phase 2
Completed	A Comparison of Infection Rates Between Two Surgical Sites NCT01263262	Mayo Clinic	—
Unknown	Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment Wi NCT01285674	Ziv Hospital	N/A
Unknown	Aminoglycoside Plasma Level Measurement in Neonates With Infection NCT01624324	Indonesia University	—
Unknown	Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss NCT01216800	Institute of Cancer Research, United Kingdom	Phase 3
Completed	Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ C NCT00716976	Children's Oncology Group	Phase 3
Active Not Recruiting	Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy NCT00683319	Children's Cancer and Leukaemia Group	—
Unknown	Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity? NCT00578760	University Health Network, Toronto	N/A
Completed	Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liv NCT00652132	University of Birmingham	Phase 3
Completed	Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin NCT00477607	US Department of Veterans Affairs	Phase 2 / Phase 3
Completed	The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans NCT01139281	University of Brasilia	Phase 2
Completed	Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin NCT00458887	Children's Oncology Group	—